Q2 2023 · 13F-HR
GREAT POINT PARTNERS LLCholdings as filed
Filed 2023-08-14 · accession 0001172661-23-003165
$510.8M
Reported value
40
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 02083G100 | NVLSEUR | ALPINE IMMUNE SCIENCES INC | $34.6M | 6.77% | 3,363,688 | Common | SHARED |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $31.2M | 6.12% | 677,426 | Common | SHARED |
| 92243G108 | PCVX | VAXCYTE INC | $29.4M | 5.76% | 589,211 | Common | SHARED |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $28.1M | 5.50% | 1,550,184 | Common | SHARED |
| 75382E109 | — | RAPT THERAPEUTICS INC | $27.4M | 5.36% | 1,465,151 | Common | SHARED |
| 730541109 | — | POINT BIOPHARMA GLOBAL INC | $27.2M | 5.32% | 3,000,000 | Common | SHARED |
| G9TY5A101 | ZURA | ZURA BIO LTD | $27.0M | 5.29% | 3,295,000 | Common | SHARED |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $20.9M | 4.09% | 968,795 | Common | SHARED |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $20.4M | 3.99% | 530,000 | Common | SHARED |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $20.1M | 3.94% | 1,941,581 | Common | SHARED |
| 23282W605 | CYTK | CYTOKINETICS INC | $19.6M | 3.83% | 600,000 | Common | SHARED |
| 032724106 | ANAB | ANAPTYSBIO INC | $18.2M | 3.56% | 894,333 | Common | SHARED |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $17.8M | 3.49% | 297,082 | Common | SHARED |
| 30052C107 | EOLS | EVOLUS INC | $17.7M | 3.46% | 2,434,048 | Common | SHARED |
| 008064107 | — | AEROVATE THERAPEUTICS INC | $16.0M | 3.13% | 932,158 | Common | SHARED |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $14.2M | 2.77% | 123,600 | Common | SHARED |
| G01767105 | ALKS | ALKERMES PLC | $12.9M | 2.52% | 411,453 | Common | SHARED |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $12.7M | 2.49% | 772,000 | Common | SHARED |
| 68404V100 | — | OPTINOSE INC | $10.9M | 2.13% | 8,839,939 | Common | SHARED |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $9.7M | 1.90% | 598,550 | Common | SHARED |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $9.3M | 1.82% | 546,059 | Common | SHARED |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $8.8M | 1.72% | 701,392 | Common | SHARED |
| 38406L103 | — | GRACELL BIOTECHNOLOGIES INC | $8.6M | 1.69% | 2,268,057 | Common | SHARED |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $8.6M | 1.69% | 94,700 | PUT | SHARED |
| 75974E103 | — | RENEO PHARMACEUTICALS INC | $7.1M | 1.39% | 1,083,317 | Common | SHARED |
| 45845P108 | — | INTERCEPT PHARMACEUTICALS IN | $6.7M | 1.30% | 601,322 | Common | SHARED |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $6.3M | 1.24% | 350,000 | Common | SHARED |
| 37148K100 | GBIOGBX | GENERATION BIO CO | $5.6M | 1.10% | 1,022,537 | Common | SHARED |
| 427746102 | HRTX | HERON THERAPEUTICS INC | $5.5M | 1.08% | 4,737,368 | Common | SHARED |
| 00509G209 | ABOS | ACUMEN PHARMACEUTICALS INC | $5.1M | 0.99% | 1,051,267 | Common | SHARED |
| 449585108 | 1K0 | IGM BIOSCIENCES INC | $4.6M | 0.90% | 500,000 | Common | SHARED |
| 81750R102 | MCRB1EUR | SERES THERAPEUTICS INC | $4.5M | 0.88% | 938,067 | Common | SHARED |
| 74019P108 | — | PRECISION BIOSCIENCES INC | $3.9M | 0.77% | 7,469,736 | Common | SHARED |
| 83422E204 | SLDB | SOLID BIOSCIENCES INC | $3.1M | 0.60% | 584,458 | Common | SHARED |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $2.6M | 0.52% | 255,000 | PUT | SHARED |
| 87410C104 | — | TALARIS THERAPEUTICS INC | $2.0M | 0.40% | 666,033 | Common | SHARED |
| 03940C100 | ACLXGBX | ARCELLX INC | $1.2M | 0.23% | 37,500 | Common | SHARED |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $921,600 | 0.18% | 60,000 | Common | SHARED |
| 59045L106 | — | MERSANA THERAPEUTICS INC | $230,300 | 0.05% | 70,000 | CALL | SHARED |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $103,950 | 0.02% | 2,700 | PUT | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.